D. Nagel
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Co-authors
- P Stieber (18 shared papers)D. Seidel (5 shared papers)Rainer Muche (1 shared paper)Peter Cremer (1 shared paper)Barbara Labrot (1 shared paper)Harald Elster (1 shared paper)Horst Mann (1 shared paper)A. Fateh‐Moghadam (5 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Cancer (3 papers)European Journal of Clinical Investigation (1 paper)Tumor Biology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- Germany
In The Last Decade
D. Nagel
23 papers receiving 935 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 229
- Oncology 273
- Endocrinology, Diabetes and Metabolism 114
- Pulmonary and Respiratory Medicine 165
- Surgery 214
Countries citing papers authored by D. Nagel
This map shows the geographic impact of D. Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Nagel more than expected).
Fields of papers citing papers by D. Nagel
This network shows the impact of papers produced by D. Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Nagel. The network helps show where D. Nagel may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Nagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 257 | |
| 2 | 2002 | 158 | |
| 3 | 2018 | 120 | |
| 4 | Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. | 2001 | 110 |
| 5 | 2015 | 65 | |
| 6 | 1991 | 55 | |
| 7 | 2013 | 46 | |
| 8 | Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. | 1997 | 39 |
| 9 | Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis. | 1999 | 32 |
| 10 | Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. | 1997 | 25 |
| 11 | Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases. | 1998 | 14 |
| 12 | 2011 | 9 | |
| 13 | 2004 | 7 | |
| 14 | 2009 | 6 | |
| 15 | 2006 | 5 | |
| 16 | 1997 | 4 | |
| 17 | 1996 | 4 | |
| 18 | 2008 | 4 | |
| 19 | 1985 | 3 | |
| 20 | 2011 | 2 |
About D. Nagel
D. Nagel is a scholar working on Oncology, Surgery, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 970 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Research Studies (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Diagnosis and Treatment (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (229 citations), Oncology (273 citations), Endocrinology, Diabetes and Metabolism (114 citations), Pulmonary and Respiratory Medicine (165 citations) and Surgery (214 citations). D. Nagel has collaborated with scholars based in Germany. Frequent co-authors include P Stieber, D. Seidel, Rainer Muche, Peter Cremer, Barbara Labrot, Harald Elster, Horst Mann, A. Fateh‐Moghadam, Volker Heinemann and Michael Untch. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Clinical Investigation, Tumor Biology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.